Insiders Trades

★ Sign in to follow

DS

Dawn Svoronos

Executive

Theratechnologies Inc.

Cumul. flow

Total declarations

23

Company

1

▲ Purchases (21 ops.)

€193k

▼ Sales (0 ops.)

—

Latest filing published 30 Oct 2023 for Theratechnologies Inc..

Filing timeline

BuySale

Dawn Svoronos

Insider track record

Disclosed buys

21

Disclosed sells

0

Signal history

Dawn Svoronos: trading record in brief

All filings by Dawn Svoronos on record concern Theratechnologies Inc. We count 23 filings; the first trade dates from 20 April 2020 and the latest from 27 October 2023.

No open-market sale appears; the market trades are 21 purchases worth €193k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 option exercise. 2023 to date brings 3 purchases and no sales.

A typical purchase (the median) is worth €7,580. Across 21 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 30 October 2023, reports a transaction in Theratechnologies Inc. The last insider purchase was made public on 30 October 2023, 1,091 days ago. Typically, a trade is published a median of 4 days after it takes place. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.

Companies and markets linked to Dawn Svoronos

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Theratechnologies Inc. (CA)

Declarations23 total

●

4 - Director of IssuerExecutives31 Jul 2023Theratechnologies Inc.

0SEDI

242,700 sharesCommon SharesTSXSEDI:4201141

▲

4 - Director of IssuerExecutives27 Oct 2023Theratechnologies Inc.

21,646 CAD12SEDI

15,800 shares@ CA$1.377.7% of flowCommon SharesTSXSEDI:4201144

Canonical exit: 25 Jan 2024 (T+90)

▲

4 - Director of IssuerExecutives27 Oct 2023Theratechnologies Inc.

546 CAD11SEDI

400 shares@ CA$1.3650.2% of flowCommon SharesTSXSEDI:4201143

Canonical exit: 25 Jan 2024 (T+90)

▲

4 - Director of IssuerExecutives27 Oct 2023Theratechnologies Inc.

18,768 CAD12SEDI

13,800 shares@ CA$1.366.7% of flowCommon SharesTSXSEDI:4201142

Canonical exit: 25 Jan 2024 (T+90)

◇

4 - Director of IssuerExecutives20 Oct 2022Theratechnologies Inc.

0SEDI

50,000 sharesCommon SharesTSXSEDI:4020856

▲

4 - Director of IssuerExecutives24 Apr 2020Theratechnologies Inc.

1,492 CAD17SEDI

400 shares@ CA$3.730.6% of flowCommon SharesTSXSEDI:3542441

Canonical exit: 23 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives24 Apr 2020Theratechnologies Inc.

28,125 CAD18SEDI

7,500 shares@ CA$3.7511.2% of flowCommon SharesTSXSEDI:3542442

Canonical exit: 23 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives20 Apr 2020Theratechnologies Inc.

632 CAD11SEDI

200 shares@ CA$3.160.2% of flowCommon SharesTSXSEDI:3541737

Canonical exit: 19 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives20 Apr 2020Theratechnologies Inc.

8,764 CAD11SEDI

2,800 shares@ CA$3.133.5% of flowCommon SharesTSXSEDI:3541736

Canonical exit: 19 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives21 Apr 2020Theratechnologies Inc.

12,564 CAD17SEDI

3,600 shares@ CA$3.494.9% of flowCommon SharesTSXSEDI:3541755

Canonical exit: 20 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives20 Apr 2020Theratechnologies Inc.

29,726 CAD12SEDI

8,900 shares@ CA$3.3411.7% of flowCommon SharesTSXSEDI:3541744

Canonical exit: 19 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives20 Apr 2020Theratechnologies Inc.

1,005 CAD11SEDI

300 shares@ CA$3.350.4% of flowCommon SharesTSXSEDI:3541748

Canonical exit: 19 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives20 Apr 2020Theratechnologies Inc.

12,720 CAD12SEDI

4,000 shares@ CA$3.185.0% of flowCommon SharesTSXSEDI:3541738

Canonical exit: 19 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives20 Apr 2020Theratechnologies Inc.

11,638 CAD11SEDI

3,500 shares@ CA$3.3254.6% of flowCommon SharesTSXSEDI:3541741

Canonical exit: 19 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives20 Apr 2020Theratechnologies Inc.

25,308 CAD12SEDI

7,600 shares@ CA$3.3310.0% of flowCommon SharesTSXSEDI:3541742

Canonical exit: 19 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives21 Apr 2020Theratechnologies Inc.

16,656 CAD18SEDI

4,800 shares@ CA$3.476.5% of flowCommon SharesTSXSEDI:3541754

Canonical exit: 20 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives20 Apr 2020Theratechnologies Inc.

635 CAD11SEDI

200 shares@ CA$3.1750.3% of flowCommon SharesTSXSEDI:3541746

Canonical exit: 19 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives20 Apr 2020Theratechnologies Inc.

9,628 CAD11SEDI

2,900 shares@ CA$3.323.8% of flowCommon SharesTSXSEDI:3541740

Canonical exit: 19 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives21 Apr 2020Theratechnologies Inc.

5,865 CAD17SEDI

1,700 shares@ CA$3.452.3% of flowCommon SharesTSXSEDI:3541753

Canonical exit: 20 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives20 Apr 2020Theratechnologies Inc.

35,600 CAD12SEDI

10,000 shares@ CA$3.5614.0% of flowCommon SharesTSXSEDI:3541750

Canonical exit: 19 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives20 Apr 2020Theratechnologies Inc.

332 CAD11SEDI

100 shares@ CA$3.3150.1% of flowCommon SharesTSXSEDI:3541739

Canonical exit: 19 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives21 Apr 2020Theratechnologies Inc.

684 CAD17SEDI

200 shares@ CA$3.420.3% of flowCommon SharesTSXSEDI:3541751

Canonical exit: 20 Jul 2020 (T+90)

▲

4 - Director of IssuerExecutives21 Apr 2020Theratechnologies Inc.

52,150 CAD19SEDI

14,900 shares@ CA$3.5020.5% of flowCommon SharesTSXSEDI:3541756

Canonical exit: 20 Jul 2020 (T+90)

23 of 23 declarations